DiStefano et al., 1990 - Google Patents
Regulation of Schwann cell surface and truncated nerve growth factor receptors in vitro by axonal componentsDiStefano et al., 1990
- Document ID
- 8193524485090209336
- Author
- DiStefano P
- Chelsea D
- Publication year
- Publication venue
- Brain research
External Links
Snippet
A tissue culture model was designed to characterize the ability of axonal membranes and detergent extracts of membranes to down regulate nerve growth factor (NGF) receptors on the Schwann cell surface. The findings establish that (i) axons from intact neurons, as well …
- 210000004116 Schwann Cells 0 title abstract description 73
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5441937A (en) | Neurotrophic factor | |
Sendtner et al. | Synthesis and localization of ciliary neurotrophic factor in the sciatic nerve of the adult rat after lesion and during regeneration. | |
Koliatsos et al. | Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo | |
Johnson Jr et al. | Expression and possible function of nerve growth factor receptors on Schwann cells | |
McKerracher et al. | Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth | |
Cheng et al. | NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults | |
DE69533698T2 (en) | Pantropic Neurotropic Factors | |
Pincelli et al. | Nerve growth factor: its significance in cutaneous biology | |
Williams et al. | High ciliary neuronotrophic specific activity in rat peripheral nerve | |
Mohiuddin et al. | Focally administered nerve growth factor suppresses molecular regenerative responses of axotomized peripheral afferents in rats | |
Nonomura et al. | Neurotrophic effect of brain-derived neurotrophic factor on basal forebrain cholinergic neurons in culture from postnatal rats | |
RU98100114A (en) | USE OF NEURO-DERIVATED EMBRYONIC CELL LINES FOR TRANSPLANTATION THERAPY | |
CA2335966A1 (en) | Method for inducing growth and enhancing survival of nervous tissue | |
Maeda et al. | Regenerating sensory neurones of diabetic rats express reduced levels of mRNA for GAP-43, γ-preprotachykinin and the nerve growth factor receptors, trkA and p75NGFR | |
Mokuno et al. | Regulation of Schwann cell nerve growth factor receptor by cyclic adenosine 3′, 5′‐monophosphate | |
DiStefano et al. | Regulation of Schwann cell surface and truncated nerve growth factor receptors in vitro by axonal components | |
Vantini et al. | Neurotrophic factors: from physiology to pharmacology? | |
Lapchak et al. | Neurotrophins in the central nervous system | |
US7144983B1 (en) | Pantropic neurotrophic factors | |
Vantini | The pharmacological potential of neurotrophins: a perspective | |
Welcher et al. | Molecular approaches to nerve regeneration | |
Liberini et al. | Effects of nerve growth factor in primate models of neurodegeneration: Potential relevance in clinical neurology | |
FI93925C (en) | A method for producing a water - soluble factor derived from the regenerating optic nerves of fish | |
Bonyhady et al. | An analysis of peripheral neuronal survival factors present in muscle | |
Vogelsberg et al. | Cholinergic deficits in aged rat spinal cord: restoration by GM1 ganglioside |